Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.

Adept Technology Inc. (NASDAQ: ADEP) shares jumped 21.31 percent to close at $18.33 a share Friday. The stock traded between $16.30 and $18.69 on volume of 873,567 shares traded. The company revenues were $14.6 million for the second quarter of fiscal 2014, an increase of 35.0 percent when compared to a year ago. Shares of Adept Technology are up approximately 8.0 percent year-to-date.

Get more information on Adept Technology and free access to the in-depth equity report at:
www.FiveStarEquities.com/ADEP

Cytokinetics, Inc. (NASDAQ: CYTK) shares surged 26.09 percent to close at $8.70 a share Friday. The stock traded between $7.22 and $9.24 on volume of 4.38 million shares traded. The company reported revenues were $24.3 million for the fourth quarter of 2013, compared to just $2.2 million a year ago. Shares of Cytokinetics are up approximately 33.0 percent year-to-date.

Get more information on Cytokinetics and free access to the in-depth equity report at:
www.FiveStarEquities.com/CYTK

SMART Technologies Inc. (NASDAQ: SMT) shares soared 28.05 percent to close at $3.05 a share Friday. The stock traded between $3.00 and $3.65 on volume 3.84 million shares traded. The company reported an adjusted net income of $9.0 million for the third quarter of fiscal 2014, compared to a loss of $2.7 million a year ago. Shares of SMART Technologies are up approximately 40.0 percent year-to-date.

Get more information on SMART Technologies and free access to the in-depth equity report at:
www.FiveStarEquities.com/SMT

Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) shares spiked 18.29 percent to close at $4.98 a share Friday. The stock traded between $4.41 and $5.08 on volume 6.04 million shares traded. The company announced that it is scheduled to present at two upcoming conferences; the Leerink Global Healthcare Conference and the 2014 RBC Capital Markets' Global Healthcare Conference. Shares of Sunesis Pharmaceuticals have are up approximately 5.0 percent year-to-date.

Get more information on Sunesis Pharmaceuticals free access to the in-depth equity report at:
www.FiveStarEquities.com/SNSS

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Five Star Equities
info@fivestarequities.com